Medicine Description janaglip-plus 50/1000mg
janaglip plus 50/1000mg tablets is a medication that combines two active ingredients: Metformin and Sitagliptin. Metformin primarily reduces hepatic glucose production and enhances insulin sensitivity, promoting better utilization of glucose by the body’s cells. Sitagliptin, on the other hand, inhibits the enzyme DPP-4, which breaks down incretin hormones. By prolonging the action of these hormones, Sitagliptin enhances insulin secretion in response to meals and lowers glucagon levels, contributing to a more balanced blood glucose level postprandially. Together, these mechanisms work synergistically to control blood sugar levels in individuals with type II diabetes.
Indications and Uses of janaglip plus 50/1000mg tablets
- Management of type II diabetes mellitus
- Improvement of glycemic control when diet and exercise alone are insufficient
- As an adjunct to lifestyle modifications for better blood sugar management
Side Effects of janaglip plus 50/1000mg tablets
- Nausea
- Diarrhea
- Abdominal discomfort
- Headache
- Hypoglycemia (when used with other antidiabetic agents)
- Potential risk of lactic acidosis (rare but serious)
Storage and Handling
Store in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children.
Patient Advice and Precautions
Monitor blood glucose levels regularly to assess the effectiveness of the treatment.Adhere to dietary recommendations and exercise regimens as advised by healthcare providers.Be cautious of signs of low blood sugar, especially if combined with other medications.Inform healthcare professionals of any additional medications or supplements being taken to avoid drug interactions.Consult a healthcare provider before making any changes to the medication regimen.